CEACAM1 and central nervous system cancer: Preliminary studies showed the abnormal expression of carcinoembryonic antigen cell adhesion molecule 1 (CEACAM1) in glioma tissues, which was closely associated with multiple clinicopathological factors of patients with glioma [6].